Indian Journal of Orthopaedics Surgery
Official Publication of Innovative Education and Scientific Research Foundation
Official Publication of Innovative Education and Scientific Research Foundation
Print ISSN:-2395-1354
Online ISSN:-2395-1362
CODEN : IJOSHC
Original Article
Author Details :
Volume : 8, Issue : 3, Year : 2022
Article Page : 219-221
https://doi.org/10.18231/j.ijos.2022.038
Abstract
Background: CRIF with K-wire fixation is the treatment of choice in fractures suprracondylar humerus in children. The study was done in thirty patient to evaluate the outcome of percutaneous lateral pinning using k wire.
Materials and Methods: Thirty case of displaced fracture supracondylar in children managed with CRIF with percutaneous lateral pinning using k- wire. The average age group of children was 7.4 year (minimum 5year of age and maximun-13year year). The fracture was immobilised for three weeks. Follow up was done at 3, 6, 9.12.24 week and all the complication were recorded. Evaluation was done on the basis of Flynn’s criteria by measuring loss of elbow motion and carrying angle.
Results: Out of 30 patient 26 patients had excellent results, 2 patient had good results, 1 patient had fair result and 1 patient had poor result according to Flynn’s criteria.
Conclusion: CRIF with k –wire by percutaneous lateral pinning in displaced fracture supracondylar humerus in children is an excellent modality of treatment with good functional outcome and minimum complication.
Keywords: Supracondylar humerus fracture, CRIF with k wire, Lateral pinning. Flynn’s criteria.
How to cite : Jangde P K, Ghilley S K, To evaluate the outcome of fracture supracondylar humerus managed with percutaneous lateral pinning in children. Indian J Orthop Surg 2022;8(3):219-221
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
